A phase 2 study of combination chemotherapy for hepatocellular carcinoma using Miripla (SM11355) and IA-call (DDP-H)
Phase of Trial: Phase II
Latest Information Update: 10 May 2017
At a glance
- Drugs Cisplatin (Primary) ; Miriplatin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 01 Apr 2017 Status changed from recruiting to completed.
- 16 Jan 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 21 Sep 2011 New trial record